This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery

This study has been terminated.
(Insufficient recruitment over time.)
Information provided by (Responsible Party):
Dan Azagury, University Hospital, Geneva Identifier:
First received: November 19, 2007
Last updated: September 4, 2013
Last verified: September 2013
The aim of this study is to demonstrate the influence of peri-operative nutrition on the post-operative complications, preservation of lean body mass and length of stay after gastrectomy or oesophagectomy.

Condition Intervention
Stomach Neoplasms Esophageal Neoplasms Dietary Supplement: Impact Dietary Supplement: Glucose load

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Perioperative Nutrition in Upper GI Cancer Surgery (Oesophagectomy or Gastrectomy)

Resource links provided by NLM:

Further study details as provided by Dan Azagury, University Hospital, Geneva:

Primary Outcome Measures:
  • Rate of post-operative complications [ Time Frame: 30 days ]
  • Length of stay [ Time Frame: 30 days ]

Secondary Outcome Measures:
  • Quality of life [ Time Frame: 1 year ]
  • Body composition [ Time Frame: 1 year ]

Enrollment: 43
Study Start Date: November 2007
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Nutrition
Pre-operative immunonutritrion, pre-operative glucose load, post-operative early immunonutrition
Dietary Supplement: Impact
Preoperative 5 day oral Impact and early post-operative enteral Impact
Dietary Supplement: Glucose load
Pre-operative glucose load: 800 ml of PreOp (Nutricia) 12 h before surgery; 400 ml of PreOp (Nutricia) 2 hours before surgery
Other Name: PreOp Nutricia
No Intervention: Control
No immunonutrition, no glucose load, no early enteral immunonutrition


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Surgery for Upper GI cancer
  • Age over 18
  • Informed consent

Exclusion Criteria:

  • Major swallowing disorders
  • Dementia or other psychological state precluding compliance and understanding of research protocol
  • Pre-existing enteral or parenteral nutrition
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00560846

Hôpitaux Universitaires Genève
Geneva, Switzerland, 1204
Sponsors and Collaborators
Dan Azagury
Principal Investigator: Dan E Azagury, MD Geneva University Hospital
  More Information

Responsible Party: Dan Azagury, Medecin adjoint du chef de service, University Hospital, Geneva Identifier: NCT00560846     History of Changes
Other Study ID Numbers: CER: 07-123
Study First Received: November 19, 2007
Last Updated: September 4, 2013

Keywords provided by Dan Azagury, University Hospital, Geneva:
Gastric cancer
Esophageal cancer
Surgical complications

Additional relevant MeSH terms:
Stomach Neoplasms
Esophageal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases
Head and Neck Neoplasms
Esophageal Diseases processed this record on August 21, 2017